Perspectives for repurposing drugs for the coronavirus disease 2019

Perspectives for repurposing drugs for the coronavirus disease 2019

The newly emerged 2019 novel coronavirus (CoV), named as severe acute respiratory syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East respiratory syndrome CoV (MERS-CoV), has been associated with high infection rates with over 36,405 deaths. In the absence of approved market...

Full description

Bibliographic Details
Main Authors: Sarah S Cherian, Megha Agrawal, Atanu Basu, Priya Abraham, Raman R Gangakhedkar, Balram Bhargava
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Medical Research
Subjects:
coronavirus - covid-19 - drugs - host-based - repurposing - severe acute respiratory syndrome coronavirus 2 - virus-based
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=151;issue=2;spage=160;epage=171;aulast=Cherian

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=151;issue=2;spage=160;epage=171;aulast=Cherian

Similar Items